This paper reports the synthesis of a panel of small molecules with arylamides and arylsulfonamides groups and their biological activity in inhibiting nucleotide exchange on human Ras. The design of these molecules was guided by experimental and molecular modelling data previously collected on similar compounds. Aim of this work is the validation of the hypothesis that a phenyl hydroxylamine group linked to a second aromatic moiety generates a pharmacophore capable to interact with Ras and to inhibit its activation. In vitro experiments on purified human Ras clearly show that the presence of an aromatic hydroxylamine and a sulfonamide group in the same molecule is a necessary condition for Ras binding and nucleotide exchange inhibition. The inhibitor potency is lower in molecules in which either the hydroxylamine has been replaced by other functional groups or the sulfonamide has been replaced by an amide. In the case both these moieties, the hydroxylamine and sulfonamide are absent, inactive compounds are obtained. © 2010 Bentham Science Publishers Ltd.
Colombo, S., Palmioli, A., Airoldi, C., Tisi, R.A., Fantinato, S., Olivieri, S., et al. (2010). Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors. CURRENT CANCER DRUG TARGETS, 10(2), 192-199.
|Citazione:||Colombo, S., Palmioli, A., Airoldi, C., Tisi, R.A., Fantinato, S., Olivieri, S., et al. (2010). Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors. CURRENT CANCER DRUG TARGETS, 10(2), 192-199.|
|Tipo:||Articolo in rivista - Articolo scientifico|
|Carattere della pubblicazione:||Scientifica|
|Titolo:||Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors|
|Autori:||Colombo, S; Palmioli, A; Airoldi, C; Tisi, RA; Fantinato, S; Olivieri, S; De Gioia, L; Martegani, E; Peri, F|
|Data di pubblicazione:||2010|
|Rivista:||CURRENT CANCER DRUG TARGETS|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.2174/156800910791054185|
|Appare nelle tipologie:||01 - Articolo su rivista|